Main > > >CORONARY ARTERY DISEASE. *
Cardio.>Coronary Artery Disease. Chronic Total Occlusion (CTO). ReCanalization. MicroCatheter.
USA Approval Date: 2017. 10.26.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 09.09.
Cardio.>Coronary Artery Disease. DIAG.:
Catheterization. Vascular Closure Sys-
tem.
(*) Company; Patent Assignee; Trade-
Mark & Web-Site Available on Request
UpDate: 2019. 03.14.
Cardio.>Coronary Artery Disease. DIAG.:
Fractional Flow Reseeve (FFR). Measure-
ment: Pressure GuideWire.
USA Approval (3G) Date: 2020. 01.13.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 09.10.
Cardio.>Coronary Artery Disease. DIAG.:
Fractional Flow Reserve (FFR)+MicroCa-
theter 2G.
FFR 2G Global Launch : 2017. 10.27.
MicroCa 2G Global Launch: 2020. 07.09.
(*) Company; Patents; TradeMarks &
Web-Sites Available on Request.
UpDate: 2020. 08.25.
Cardio.>Coronary Artery Disease. DIAG.: System>2 Components:
1. a device that records 3D electric
currents via five electrodes attached
to the thorax & collects data from
the resting heart for approximately
four minutes &
2. AI Software APP. that uses multiple
algorithms and machine learning
methods to evaluate the measurements
result, along with a supplementary standard ECG report, are available about one minute later.
No Radiation Exposure
Non-Invasive
Patent>Pending
Study Published in Journal of Electro- cardiology
EU CE Mark: Yes.
(*) Company & Web-Sites Available on
Request.
UpDate: 2020. 01.14.
Cardio.>Coronary Artery Disease. Lipid Core Plaque (LCP). Detection & Analysis. IntraVascular UltraSound (IVUS)+Near InfraRed Spectroscopy (NIRS). Heart Attack (Myocardial Infarction) Prognos- tics.
JP Approval Date : 2017. 08.
JP Launch Date : 2018. 07.31.
USA Approval Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.11.
Cardio.>Coronary Artery Disease. Multi Vessel CAD. NonInvasive Evaluation. Fractional Flow Reserve (FFR) Device.
3D Reconstruction of Entire Coronary Tree with FFR values along each Vessel.
Delivers Objective FFR Guidance needed
to optimize PCI therapy decisions.
Derived from Routine X-Rays ACQuired during a diagnostic Angiogram procedure.
Performed Intra-Procedurally during Coronary Angiography.
Use during PCI Intervention.
JP Approval Date: 2019. 12.11.
USA Approval Date: 2018. 12.20.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 12.12.
Cardio.>DIAG.: GuideWire Fractional Flow Reserve (FFR)
During Percutaneous Coronary Interven-
tion (PCI).
Indications:
to direct a catheter through a blood vessel and to measure blood pressure
in the heart and in the coronary blood vessels.
Patient Outcomes Improvement>
>over Angiography alone.
EU Launch Date: 2016. 05.18.
(*) Company; Patents; TradeMark & Web-
Sites Available on Request.
UpDate: 2019. 03.12.
Cardio.>Healthy Individuals. Heart Di- sease. Early Detection.
Correlation between HRV (Heart Rate>
>Variability) & the presence of myocar-
dial ischemia in healthy individuals
without known coronary artery disease
(CAD)
Effortless Stress Test Alternative for>
>early detection of myocardial ischemia
in relatively healthy individuals.
test analyzes 20 minutes of heartrate
data obtained by wearing a standard
heartrate recorder (e.g., Heartrate
strap, smartwatch or bracelet) without
the need for stressful maneuvers or
heart strain making it especially
advantageous for the elderly, impaired,
and weight challenged.
Machine Learning AI Algorithms
EU CE Mark Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 11.13.
Cardio.>TREAT.: BioResorbable Scaffold (“BRS”).
EU Launch Date: 2018. 10.31.
(*) Company; Patent; TradeMarks & Web-
Sites Available on Request.
UpDate: 2019. 03.31.
Cardio.>TREAT.: Co-Cr Stent.>Bifurcation (Site where One Artery Branches from Another).
EU Approval Date : 2011. 05.18.
USA Approval Date: 2017. 03.06.
(*) Companies; Patents; TradeMark & Web-
Sites Available on Request.
UpDate: 2019. 03.31.
Cardio.>TREAT.: Orbital Atherectomy System (OAS). Classic Crown+GuideWire.
EU 1st Patient : 2021. 02.08.
EU CE Mark Date : 2021. 01.
JP Approval Date : 2019. 01.02.
USA Approval Date: 2019. 09.24.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 02.09.
Cardio.>TREAT.: Planning Software.
USA Clearance Date: 2019. 09.12.
(*) Company; Patents; Product Name &
Web-Site Available on Request.
UpDate: 2019. 10.01.
Cardio.>TREAT.: PolyPhosphazene Nano-Coated Non-Drug Eluting Co-Cr Stent.
Minimum 1-month (Dual AntiPlatelet Ther- apy (DAPT) Requirement.
EU Approval Year : 2012.
EU Launch Year : 2013.
USA Approval Date: 2017. 03.01.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.15.
Cardio.>TREAT.: Ridaforolimus-Eluting Coronary Stent System.
About Percutaneous Coronary Intervention (PCI).
PCI is a NonSurgical Procedure that often uses a Catheter to place a Stent to Open Blocked Coronary Arteries caused by "Coronary Artery Disease. (CAD)."
EU Approval Date : 2017. 10.26.
USA Approval Date: 2017. 11.30.
(*) Company; Patents; TradeMarks & Web-
Sites Available on Request.
UpDate: 2017. 12.01.
Cardio.>TREAT.: Sirolimus Drug Eluting
Balloon (DEB).
EU>CE Mark Date: 2020. 05.14.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 02.07.
Cardio.>TREAT.: Sirolimus Eluting Stent.
EU Approval Year : 2011.
USA Approval Date: 2019. 02.22.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 09.14.
DIAGNOSTICS: Artificial Intelligence.
Computed Tomography Imaging Scan.
USA Approval Date: 2018. 07.12.
(*) Company: Zebra Medical Vision Ltd.
UpDate: 2019. 11.08.
DIAGNOSTICS: Technetium-Labeled Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) Agent.
(*) Company : Lantheus Medical Imaging,
Inc.
Patent : Expired
TradeMark: Cardiolite
Web-Site : www.cardiolite.com/
UpDate: 2019. 03.31.
Risk Reduction: Clopidogrel BiSulfate
Tablets. Brand.
USA>Approved.
(*) Company : Bristol-Myers Squibb/Sa-
nofi Pharmaceuticals
Partnership
Patent : Expired.
TradeMark: Plavix.
UpDate: 2019. 04.15.
TREAT.: Amlodipine Besylate. Tab. Brand.
(*) Company : Pfizer.
TradeMark: Norvasc.
UpDate: 2019. 03.27.
TREAT.: Amlodipine Besylate. Tab. Gene-
ric.
(*) Company: Teva Pharma.
UpDate: 2019. 03.27.
TREAT.: Amlodipine Oral Suspension.
USA Approval Date: 2019. 07.10.
(*) Company : Azurity Pharma.
TradeMark: Katerzia
UpDate: 2019. 07.14.
TREAT.: Stent.
EU Approval Date : 2017. 10.30.
USA Approval Date: 2018. 05.23.
(*) Company : Abbott.
TradeMark: Xience Sierra
UpDate: 2019. 03.15.
>CORONARY ARTERY DISEASE. *'s products
This section has no products